{
    "applicationNumber": "BR 11 2022 026223-0",
    "filingDate": "18/06/2021",
    "grantDate": null,
    "title": "ANTICORPO ANTI-C5A ISOLADO OU FRAGMENTO DE LIGA\u00c7\u00c3O AO ANT\u00cdGENO DO MESMO, MOL\u00c9CULA DE \u00c1CIDO NUCLEICO ISOLADA, VETOR, C\u00c9LULA HOSPEDEIRA ISOLADA, M\u00c9TODOS PARA PRODUZIR UM ANTICORPO ANTI-C5A OU FRAGMENTO DE LIGA\u00c7\u00c3O AO ANT\u00cdGENO, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, E USO DA MESMA",
    "nationalPhaseDate": [
        "21/12/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT CN2021/100863",
        "pctDate": "18/06/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "CN",
            "priorityNumber": "PCT/CN2020/098081",
            "priorityDate": "24/06/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2713"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2736"
        }
    ],
    "inventors": [
        "PINGXIA ZHU",
        "ZHONG LI"
    ],
    "holders": [
        289687
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 39/395",
        "C07K 16/18",
        "A61P 17/00",
        "C12N 15/13"
    ]
}